London– Hikma Pharmaceuticals in the US joined government officials and non-profit leaders recently at a naloxone awareness and training event organized and hosted by Rep. Earl L. “Buddy” Carter of Georgia. This important educational event took place at Groves High School in Savannah, Ga. ahead of National Fentanyl Awareness and Prevention Day.
Hikma’s participation is part of its ongoing partnership with U.S. government and community leaders and marks a milestone as Hikma celebrates donating more than 600,000 doses of naloxone over the last three years.
The U.S. Centers for Disease Control and Prevention (CDC) estimates that more than 107,000 Americans died from drug overdoses in 2023, with most deaths attributed to illicit fentanyl. Hikma is working closely with leading government officials like Rep. Carter and the White House Office of National Drug Control Policy (ONDCP) to expand access to life-saving naloxone.
These actions build on Hikma’s long-standing commitment to working with government officials, health care providers, non-profit organizations and the public health community to ensure naloxone is widely accessible to all who can benefit from it. For more than 20 years, Hikma has been working with communities across the U.S. to provide medicines that help people recover overdoses and from opioid use disorder.
Also Read: Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business
“Naloxone training events like Congressman Carter’s help build understanding of this vital tool that individuals, families, first responders and communities can quickly use to reverse overdoses and save lives, and we are proud to support efforts to expand availability of this essential medicine, As a U.S.-based manufacturer of multiple forms of overdose reversal medicines and treatments for opioid use disorder, Hikma is proud to have donated more than 600,000 doses of naloxone over the last three years.” said Dr. Hafrun Fridriksdottir, President of Hikma’s Generics business.
Earlier this summer, Rep. Carter introduced a resolution to recognize National Fentanyl Prevention and Awareness Day on Aug. 21. This is one of the many important actions he’s taken to expand access to naloxone including legislation to have the life-saving medicine in schools and calling for it to be available in the U.S. House of Representatives buildings.
Hikma manufactures multiple forms of naloxone including generic injectable vials and prefilled syringes made in New Jersey and KLOXXADO® (naloxone 8mg) intranasal spray produced in Ohio. Ahead of International Overdose Awareness Day on Aug. 31, Hikma is reaffirming its commitment to expanding access to the full range of naloxone available and partnering with diverse groups as part of the “Together We Can,” theme.
